New MRD Assessment Data Using clonoSEQ® To Be Presented at 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

Read More
Image of Chad and Harlan

Welcome to the Age of Immune Medicine

In 2009, Harlan Robins made a breakthrough that created a window into the adaptive immune system the world hadn’t thought possible. Together, Harlan and his brother Chad, founded Adaptive to meet the worldwide demand for immunosequencing technology. Over the past decade, we have developed our proprietary immune medicine platform to read and translate the adaptive immune system at scale and with precision in order to use its capabilities in the clinic.

And now, Adaptive is ready to evolve and generate opportunities across life sciences research, clinical diagnostics, and drug discovery.

Our future holds bold discoveries, building on a platform that can be deployed at speed and scale with the aim to launch universal diagnostics.

Tech, meet biotech.

Adaptive is leveraging advances in computing to translate vast systems of biology into data. It is a massive but achievable challenge that we are uniquely able to solve.

Transformational ideas need inspirational leaders.

Polaroid images of adaptive staff at work

Not just a workplace.
A growplace.

Adaptive is powering immune medicine in the most unique way—and we’re looking for individuals who want to build a story, not just a resume. If you want to go beyond the impossible—Adaptive is where you’ll discover your story. You’ll tackle big, interesting, highly impactful problems that lead to a future you can help write.